Neoadjuvant Phase II Study of Pembrolizumab And Carboplatin Plus Docetaxel in Triple Negative Breast Cancer

Name: Neoadjuvant Phase II Study of Pembrolizumab And Carboplatin Plus Docetaxel in Triple Negative Breast Cancer
License: Public Domain

University of Kansas Medical Center

ClinicalTrials.gov · Datasets · License: Public Domain

triple-negative breast cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 387158
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.